Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
about
Acute lymphoblastic leukaemiaPotential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome BrainJAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indicationsDiagnosis and subclassification of acute lymphoblastic leukemiaGenomic profiling of B-progenitor acute lymphoblastic leukemiaRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineStructural reorganization of the interleukin-7 signaling complexStructural basis of the proinflammatory signaling complex mediated by TSLPLNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitorsUse of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemiaTSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation.The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.Childhood B-acute lymphoblastic leukemia: a genetic update.Activation of JAK2-V617F by components of heterodimeric cytokine receptorsGenomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profilesKinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms.BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaHSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humansCRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis.Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase.Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.IL-7 in human health and disease.Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL.Next-generation cDNA screening for oncogene and resistance phenotypes.Rapid Identification of Therapeutic Targets in Hematologic Malignancies via Functional Genomics.Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemiaMutations in G protein β subunits promote transformation and kinase inhibitor resistanceGain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemiaEnu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 allele.Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignanciesMutations in the transmembrane and juxtamembrane domains enhance IL27R transforming activityUnderstanding the biology of CRLF2-overexpressing acute lymphoblastic leukemiaIntegrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target.Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibitionActivity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeOutcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.
P2860
Q24602387-4142939B-0EA6-4ED4-A825-D4522021B972Q26765647-AAEF38E1-B11F-4714-9758-369F45E1DFF1Q26782539-24C45037-3459-4C69-AAC2-C489299B6768Q26824387-63271F76-553B-44B2-A608-E3AEBD7EC740Q26829976-1C8F6414-E6A7-46EB-B97C-38B34546E09EQ26864460-3137259A-C3D5-4397-BA25-43ED678CDF81Q27677110-D377CB5B-25C0-43C0-A1EF-15670102A179Q27689496-7FEF2CB3-FED4-40F8-9BFF-F133688B85FBQ28274115-AAC68FF4-5A5E-4452-BD61-4304F66B8222Q28390558-4E2D1B96-896C-4A45-B746-4ACA8E1ACC9FQ30486787-A370E28E-1264-4BDB-BA31-54D319E2FB35Q33691942-2A0D532A-5867-4BA2-A81D-A1FD3DDD5358Q33698398-0FCF6AC4-2DB4-40E7-8BBA-3E6F12150E90Q33777616-96DBFD3C-A31D-471F-A5CD-D6335AD75098Q33883366-B8CCCF4E-27E6-4CA4-9505-F7F8180C2A4DQ33938184-0E16EE18-8550-4682-BED6-13B397795747Q34021753-ACA1D755-2481-4E48-87CC-8E8F5EC098C0Q34033206-522D0DB5-1CF3-4EF1-89DA-4712C8811F8FQ34162151-EF1EC62E-1383-4E0A-8E4B-4F904206C99EQ34168482-41755177-EF16-4AC3-96FB-0DBCE6DDEA97Q34182738-5FB8B079-3361-4A84-A1BF-67EAF8A9712CQ34213539-0D4BC459-C2BB-495E-94C4-36466A1D0DBDQ34260682-5B28C68D-9424-41FE-97D5-CC2CBE77A2D4Q34325528-F1062FF7-A04B-49FE-AE13-64B828C69AA1Q34474239-9D670C97-0ED0-4CC7-88FE-6244AF346D57Q34654334-8C36863A-714D-41F5-A34F-68D794A4B5F1Q34755687-1C2BA9E6-EE09-4F06-9EB4-68292B1E69A1Q34893087-30B6BBF6-FB73-4C81-BEFC-D20BA267AC96Q34973772-D39B6C7B-B0A0-49F5-99F3-8A300F4D7F2FQ35002007-98C569B6-6911-4355-B815-135218C7AF23Q35005652-0D0C5303-5DE9-4906-BE1D-339232A335EAQ35132241-C9BD3E0E-D20F-4BF4-A3A7-8AF1C22BFFFFQ35134457-1B505CF2-6683-4A96-B56C-CBBD6A169C56Q35500533-E47AB3FA-3668-4985-9EA5-9D9E26BE66D6Q35572318-819A3AD3-06EA-4685-8DB5-91596279931AQ35760845-7343586B-F24A-4447-8A1F-6F4066777ADEQ35861111-C54F0AEB-7C73-4BD4-9887-F27B4BF8F3C3Q35876592-F07BB898-6ED2-4080-A6FB-57382F17BB4EQ35885293-8042A80A-6CE3-4D9A-A1AE-16EFC21C5390Q35904943-49D98EA1-8782-4C1F-8E23-9FF5D8CFD904
P2860
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
@ast
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
@en
type
label
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
@ast
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
@en
prefLabel
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
@ast
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
@en
P2093
P2860
P50
P356
P1476
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
@en
P2093
Akinori Yoda
Alfonso Piciocchi
Constantine Mitsiades
Daniel J DeAngelo
David A Frank
David M Weinstock
James D Griffin
James E Bradner
Jeffrey L Kutok
Jennifer R Brown
P2860
P304
P356
10.1073/PNAS.0911726107
P407
P577
2009-12-15T00:00:00Z